510(k) K973101

PROSTATE SPECIFIC ANTIGEN METHOD by Dade Chemistry Systems, Inc. — Product Code LTJ

K973101 is an FDA 510(k) premarket notification submitted by Dade Chemistry Systems, Inc. for the device "PROSTATE SPECIFIC ANTIGEN METHOD". The FDA issued a decision of Substantially Equivalent on September 18, 1997. The device falls under product code LTJ (Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers), a Class II device regulated under 21 CFR 866.6010. Dade Chemistry Systems, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 18, 1997
Date Received
August 19, 1997
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
Device Class
Class II
Regulation Number
866.6010
Review Panel
IM
Submission Type